Herbert I. Hurwitz

Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer

Herbert I. Hurwitz, Louis Fehrenbacher, William Novotny et al. · New England Journal of Medicine · 2004 · 11K citations · Full text

Medicine, Oncology, Pharmacology +15

Phase II, Randomized Trial Comparing Bevacizumab Plus Fluorouracil (FU)/Leucovorin (LV) With FU/LV Alone in Patients With Metastatic Colorectal Cancer

Fairooz F. Kabbinavar, Herbert I. Hurwitz, Louis Fehrenbacher et al. · Journal of Clinical Oncology · 2002 · 1.7K citations

Medicine, Oncology, Pharmacotherapy +13

Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)

Hedy L. Kindler, Donna Niedzwiecki, Donna Hollis et al. · Journal of Clinical Oncology · 2010 · 842 citations · Full text

Medicine, Oncology, Pharmacotherapy +11

Combined Analysis of Efficacy: The Addition of Bevacizumab to Fluorouracil/Leucovorin Improves Survival for Patients With Metastatic Colorectal Cancer

Fairooz F. Kabbinavar, Julie Hambleton, R. Mass et al. · Journal of Clinical Oncology · 2005 · 689 citations

Medicine, Oncology, Pharmacology +14

Bevacizumab in Combination With Fluorouracil and Leucovorin: An Active Regimen for First-Line Metastatic Colorectal Cancer

Herbert I. Hurwitz, Louis Fehrenbacher, John D. Hainsworth et al. · Journal of Clinical Oncology · 2005 · 685 citations

Medicine, Oncology, Pharmacology +13